References
- Volkow ND, Frieden TR, Hyde PS, Cha SS. Medication-assisted therapies - tackling the opioid-overdose epidemic. N Engl J Med. 2014;370(22):2063–2066.
- National Center for Health Statistics C for DC and P. Drug Overdose Mortality by State. https://www.cdc.gov/nchs/pressroom/sosmap/drug_poisoning_mortality/drug_poisoning.htm. Published 2019. Accessed April 4, 2019.
- Hedegaard H, Warner M, Miniño AM. Drug overdose deaths in the United States, 1999–2015. NCHS data brief, no 273. Hyattsville, MD: National Center for Health Statistics; 2017.
- Hogan L, Rutherford B, Schrader Secretary DR. Drug-and alcohol-related intoxication deaths in Maryland, 2016 Maryland Department of Health and Mental Hygiene; 2017. https://bha.health.maryland.gov/Documents/Annual_Drug_Intox_Report_2016_revised.pdf
- Wen LS, Warren KE. Combatting the opioid epidemic: Baltimore’s experience and lessons learned. J Public Heal (United Kingdom). 2018;40(2):e107–e111.
- Schwartz R, Gryczynski J, O’Grady K, et al. Opioid agonist treatments and heroin overdose deaths in Baltimore, Maryland, 1995–2009. Am J Public Health. 2013;103(5):917–922.
- Bart G. Maintenance medication for opiate addiction: The foundation of recovery. J Addict Dis. 2012;31(3):207–225.
- Connery HS. Medication-assisted treatment of opioid use disorder: review of the evidence and future directions. Harv Rev Psychiatry. 2015;23(2):63–75.
- Volkow ND, Jones EB, Einstein EB, Wargo EM. Prevention and treatment of opioid misuse and addiction: a Review. JAMA Psychiatry. 2019;76(2):208–216.
- Jones CM, McCance-Katz EF. Co-occurring substance use and mental disorders among adults with opioid use disorder. Drug Alcohol Depend. 2019;197:78–82.
- Knudsen HK, Abraham AJ, Roman PM. Adoption and implementation of medications in addiction treatment programs. J Addict Med. 2011;5(1):21–27.
- Knudsen HK, Lofwall MR, Walsh SL, Havens JR, Studts JL. Physicians’ decision-making when implementing buprenorphine with new patients: conjoint analyses of data from a cohort of current prescribers. J Addict Med. 2018;12(1):31–39.
- Beetham T, Saloner B, Wakeman SE, Gaye M, Barnett ML. Access to office-based buprenorphine treatment in areas with high rates of opioid-related mortality: an audit study. Ann Intern Med. 2019;171(1):1.
- Lagisetty PA, Ross R, Bohnert A, Clay M, Maust DT. Buprenorphine treatment divide by race/ethnicity and payment. JAMA Psychiatry. 2019. 2019;76(9):979.
- Levin FR, Bisaga A, Sullivan MA, Williams AR, Cates-Wessel K. A review of a national training initiative to increase provider use of MAT to address the opioid epidemic. Am J Addict. 2016;25(8):603–609.
- Substance Abuse and Mental Health Services Administration. Medication Assisted Treatment for Opioid Use Disorders Reporting Requirements. Final Rule; 2016.
- United States Congress. Comprehensive Addiction and Recovery Act of 2016. Public Law. 2016;114(114):695–779. https://www.congress.gov/114/plaws/publ198/PLAW-114publ198.pdf.
- Knudsen HK, Abraham AJ, Oser CB. Barriers to the implementation of medication-assisted treatment for substance use disorders: The importance of funding policies and medical infrastructure. Eval Program Plann. 2011;34(4):375–381.
- Hutchinson E, Catlin M, Andrilla CHA, Baldwin LM, Rosenblatt RA. Barriers to primary care physicians prescribing buprenorphine. Ann Fam Med. 2014;12(2):128–133.
- Andrilla CHA, Coulthard C, Patterson DG. Prescribing practices of rural physicians waivered to prescribe buprenorphine. Am J Prev Med. 2018;54(6 Suppl 3):S208–S214.
- Tesema L, Marshall J, Hathaway R, et al. Training in office-based opioid treatment with buprenorphine in US residency programs: a national survey of residency program directors. Subst Abus. 2018;39(4):434–440.
- Sharfstein JM, Olsen Y. Making amends for the opioid epidemic. JAMA - J Am Med Assoc. 2019;321(15):1446.
- Knudsen HK. The supply of physicians waivered to prescribe buprenorphine for opioid use disorders in the United States: a state-level analysis. J Stud Alcohol Drugs. 2015;76(4):644–654.
- Substance Abuse and Mental Health Services Administration. Medicaid coverage and financing of medications to treat alcohol and opioid use disorders. 2014. HHS Publication No. SMA-14-4854
- University of Maryland BSEC. Opioid treatment programs in Maryland needs assessment report; 2016. https://bha.health.maryland.gov/Documents/Combined OTP Needs Assessment Report and letter11.18.16.pdf.
- Sarvet B, Gold J, Bostic JQ, et al. Improving access to mental health care for children: the Massachusetts Child Psychiatry Access Project. Pediatrics. 2010;126(6):1191–1200.
- Stein BD, Kofner A, Vogt WB, Yu H. A national examination of child psychiatric telephone consultation programs' impact on children's mental health care utilization. J Am Acad Child Adolesc Psychiatry. 2019;58(10):1016–1019.
- Gloth FM, Schwartz J. Developing a physicians' palliative care pain hotline in Maryland. Am J Hosp Palliat Care. 2000;17(1):24–28.
- Massachusetts Consultation Service for Treatment of Addiction and Pain. https://www.mcstap.com/. Published 2019.
- Universityf of Wisconsin S of M and PH. UW addiction consultation provider hotline. https://www.fammed.wisc.edu/addiction-hotline/. Published 2019. Accessed December 13, 2019.
- MATRIARC. https://psychiatry.uams.edu/clinical-care/cast-2/matriarc/. Published 2020. Accessed December 13, 2019.
- Michigan Opioid Collaborative (MOC). https://medicine.umich.edu/dept/psychiatry/programs/michigan-opioid-collaborative-moc. Accessed December 13, 2019.
- Goldschmidt RH, Graves DW. The national HIV telephone consultation service (Warmline): a clinical resource for physicians caring for African-Americans. J Natl Med Assoc. 2003;95(2 SUPPL. 2):8S–11S.
- Egan JE, Casadonte P, Gartenmann T, et al. The physician clinical support system-buprenorphine (PCSS-B): a novel project to expand/improve buprenorphine treatment. J Gen Intern Med. 2010;25(9):936–941.
- Carr CH, McNeal H, Regalado E, Nelesen RA, Lloyd LS. PAL-MED CONNECT®: a telephone consultation hotline for palliative medicine questions. J Palliat Med. 2013;16(3):263–267.
- Hilt RJ, Romaire MA, McDonell MG, et al. The partnership access line: evaluating a child psychiatry consult program in Washington state. JAMA Pediatr. 2013;167(2):162–168.
- Eaton JL, Mohr DC, Mohammad A, et al. Implementation of a novel occupational and environmental medicine specialty teleconsultation service: the VHA experience. J Occup Environ Med. 2015;57(2):173–177.
- Harrison J, Wasserman K, Steinberg J, Platt R, Coble K, Bower K. The five S's: a communication tool for child psychiatric access projects. Curr Probl Pediatr Adolesc Health Care. 2016;46(12):411–419.
- Marcus S, Malas N, Dopp R, et al. The Michigan child collaborative care program: building a telepsychiatry consultation service. Psychiatr Serv. 2019;70(9):849–852.
- Clinician Consultation Center. California Substance Use Line. https://nccc.ucsf.edu/clinician-consultation/substance-use-management/california-substance-use-line/. Published 2020. Accessed December 13, 2019.
- Grigg J, Arunogiri S, Manning V, et al. The drug and alcohol clinical advisory service: a model of telephone-delivered addiction specialist support. Drug Alcohol Rev. 2020;39(3):238–245.
- Andrilla CHA, Moore TE, Patterson DG. Overcoming barriers to prescribing buprenorphine for the treatment of opioid use disorder: recommendations from rural physicians. J Rural Heal. 2019;35(1):113–121.
- Jones CM, McCance-Katz EF. Characteristics and prescribing practices of clinicians recently waivered to prescribe buprenorphine for the treatment of opioid use disorder. Addiction. 2019;114(3):471–482.
- Pidano AE, Honigfeld L, Bar-Halpern M, Vivian JE. Pediatric primary care providers’ relationships with mental health care providers: survey results. Child Youth Care Forum. 2014;43(1):135–150.
- DeFlavio JR, Rolin SA, Nordstrom BR, Kazal LA. Analysis of barriers to adoption of buprenorphine maintenance therapy by family physicians. Rural Remote Health. 2015;15(1):1–11.
- Pearson ACS, Eldrige JS, Moeschler SM, Hooten WM. Opioids for chronic pain: a knowledge assessment of nonpain specialty providers. J Pain Res. 2016;9:129–135.
- Knickman J, Krishnan R, Pincus H. Improving access to effective care for people with mental health and substance use disorders. JAMA - J Am Med Assoc. 2016;316(16):1647–1648.
- Connors EH, Arora P, Blizzard AM, et al. When behavioral health concerns present in pediatric primary care: factors influencing provider decision-making. J Behav Health Serv Res. 2018;45(3):340–355.
- Haffajee RL, Bohnert ASB, Lagisetty PA. Policy pathways to address provider workforce barriers to buprenorphine treatment. Am J Prev Med. 2018;54(6 Suppl 3):S230–S242.
- Huhn AS, Dunn KE. Why aren’t physicians prescribing more buprenorphine? J Subst Abuse Treat. 2017;78:1–7.
- Maryland Department of Health. Federal and State Designated Rural Areas. https://pophealth.health.maryland.gov/Documents/Rural.Health/Federal and State Designated Rural Areas 11.13.2015.jpg. Published 2015. Accessed October 18, 2019.
- Platt R, Pustilnik S, Connors E, Gloff N, Bower K. Severity of mental health concerns in pediatric primary care and the role of child psychiatry access programs. Gen Hosp Psychiatry. 2018;53:12–18.
- Young A, Chaudhry HJ, Pei X, Halbesleben K, Polk DH, Dugan M. A census of actively licensed physicians in the United States, 2014. J Med Licens Discip. 2015;99(2), 11–24.
- SAMHSA. Buprenorphine Practitioner Locator | SAMHSA - Substance Abuse and Mental Health Services Administration. https://www.samhsa.gov/medication-assisted-treatment/practitioner-program-data/treatment-practitioner-locator. Accessed October 1, 2019.
- Lagisetty PA, Healy N, Garpestad C, Jannausch M, Tipirneni R, Bohnert ASB. Access to primary care clinics for patients with chronic pain receiving opioids. JAMA Netw Open. 2019;2(7):e196928.
- Braithwaite V, Nolan S. Hospital-based addiction medicine healthcare providers. J Addict Med. 2019;13(4):251–252.
- Gunderson EW, Fiellin DA, Levin FR, Sullivan LE, Kleber HD. Evaluation of a combined online and in person training in the use of buprenorphine. Subst Abus. 2006;27(3):39–45.
- Arora PG, Connors EH, Coble K, Blizzard A, Wissow L, Pruitt D. Pediatric primary care providers' use of behavioral health consultation. Psychiatr Serv. 2017;68(6):531–534.
- Davis MT, Bateman B, Avorn J. Educational outreach to opioid prescribers: the case for academic detailing. Pain Phys. 2017;2(20):S147–S151.
- Andrilla CHA, Jones KC, Patterson DG. Prescribing practices of nurse practitioners and physician assistants waivered to prescribe buprenorphine and the barriers they experience prescribing buprenorphine. J Rural Heal. 2019;36(2):187–195.
- Varghese R, Johnson K, Feng B, et al. Final research report: buprenorphine prescribing by nurse practitioners, physician assistants, and physicians after CARA 2016. 2019. https://www.macpac.gov/wp-content/uploads/2019/11/Buprenorphine-Prescribing-by-Nurse-Practitioners-Physician-Assistants-and-Physicians-after-CARA-2016.pdf.
- Miller WR, Sorensen JL, Selzer JA, Brigham GS. Disseminating evidence-based practices in substance abuse treatment: a review with suggestions. J Subst Abuse Treat. 2006;31(1):25–39.
- Arora S, Thornton K, Murata G, et al. Outcomes of treatment for hepatitis C virus infection by primary care providers. N Engl J Med. 2011;364(23):2199–2207.
- Komaromy M, Duhigg D, Metcalf A, et al. Project ECHO (Extension for Community Healthcare Outcomes): a new model for educating primary care providers about treatment of substance use disorders. Subst Abus. 2016;37(1):20–24.